Dr. Hiatt graduated from the University of Colorado School of Medicine at Denver in 1976. He works in Aurora, CO and specializes in Vascular Medicine and Cardiovascular Disease. Dr. Hiatt is affiliated with Childrens Hospital Colorado and University Of Colorado Hospital.
Jessica Kramp, Zachary Ginther, Chad Graham, Yulonda Michaud, Nicole Bogue, Gregg Smidt, Richard Meggitt, Ann Walbridge, Jessica Runyon, Robert Bohling, Kim Schroeder
"I don't believe we have enough data today to say that LDL, with a new drug class, is sufficient for approval," said Dr. William Hiatt, of the University of Colorado's School of Medicine, who voted against the drug.
Date: Jun 09, 2015
Category: Health
Source: Google
U.S. FDA panel: Novo Nordisk's liraglutide safe, effective for obesity
"Overall, there is a benefit," said Dr. William Hiatt of theUniversity of Colorado School of Medicine. "If you lose weightin this manner, patients can report an improvement in theirquality of life and in their physical functioning."
The EUCLID study principal investigator, University of Colorado School of Medicine cardiology division professor of medicine William Hiatt said the global burden of PAD is such that it necessitates further research of additional treatment options that may further reduce the risk of atherothrombotic
Date: Jul 18, 2012
Category: Health
Source: Google
FDA Panel Wants Cardio Studies for Weight-Loss Drugs
Most panelists said the strict MACE events should be primary and others should be included as secondary outcomes. William Hiatt, MD, of the University of Colorado in Aurora, Colo., said that the mechanism of action for a given drug may point to unique endpoints that would be useful to include. For e